LOGC   $2.07  0.49% Market Open

LogicBio Therapeutics Inc
Total Cash 150.00M
totalCashPerShare 5.709
EBITDA -207.00M
Total Debt 0.00
quickRatio 30.0
currentRatio 31.8
Total Revenue 156.00M
debtToEquity
Revenue/Share 6.355
ROA -0.3533
ROE -0.89612997
grossProfits
freeCashflow -421.25M
operatingCashflow -251.00M
earningsGrowth
revenueGrowth -0.91
grossMargins 0.19872
ebitdaMargins -1.32692
operatingMargins -2.71429
profitMargins -1.41026
enterpriseValue 9.49M
forwardPE
floatShares 23.63M
sharesOutstanding 26.27M
sharesShort 2.64M
sharesShortPriorMonth 2.60M
dateShortInterest
sharesPercentSharesOut 0.10%
heldPercentInsiders 0.04%
heldPercentInstitutions 0.52%
Short Ratio help_outline 11.89%
shortPercentOfFloat 0.10%
impliedSharesOutstanding
bookValue 5.875
Price To Book help_outline 1.07
earningsQuarterlyGrowth
netIncomeToCommon -220.00M
trailingEps -9.02%
forwardEps -0.04%
enterpriseToEbitda -0.05
lastDividendValue
lastDividendDate
currentQuarterEstimate -0.01 3Q 2024
institutionsCount 126
lastUpdated Oct. 21, 2024, 9:59 p.m.